<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to gabapentin (Neurontin) for chronic pain - uses, dosing, and what to expect from this nerve pain medication.">
    <meta name="keywords" content="gabapentin, Neurontin, nerve pain medication, neuropathy treatment, fibromyalgia medication">
    <title>Gabapentin (Neurontin) | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Gabapentin (Neurontin)</h1><p>A first-line treatment for nerve pain</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Gabapentin?</h2>
                <p>Gabapentin is an anticonvulsant medication widely used for chronic pain, especially neuropathic pain. While originally developed for epilepsy, it's now one of the most commonly prescribed medications for various pain conditions.<sup>1</sup></p>

                <h2>FDA-Approved Uses</h2>
                <ul>
                    <li>Postherpetic neuralgia (after shingles)</li>
                    <li>Epilepsy (adjunct)</li>
                    <li>Restless legs syndrome (Horizant)</li>
                </ul>

                <h2>Common Off-Label Uses<sup>2</sup></h2>
                <ul>
                    <li>Diabetic neuropathy</li>
                    <li>Other neuropathic pain</li>
                    <li>Fibromyalgia</li>
                    <li>Chronic back pain</li>
                    <li>Migraine prevention</li>
                </ul>

                <h2>Dosing</h2>
                <ul>
                    <li><strong>Start low</strong>: 100-300 mg at bedtime</li>
                    <li><strong>Titrate slowly</strong>: Increase every 3-7 days</li>
                    <li><strong>Typical range</strong>: 900-3600 mg/day in divided doses</li>
                    <li><strong>Max</strong>: 3600 mg/day</li>
                    <li>Reduce dose if kidney problems</li>
                </ul>

                <h2>Side Effects<sup>3</sup></h2>
                <ul>
                    <li>Dizziness</li>
                    <li>Drowsiness/fatigue</li>
                    <li>Peripheral edema (swelling)</li>
                    <li>Weight gain</li>
                    <li>Cognitive effects ("foggy")</li>
                    <li>Coordination problems</li>
                </ul>

                <h2>Important Information</h2>
                <ul>
                    <li>Takes weeks to reach full effect</li>
                    <li>Must taper off slowly</li>
                    <li>Some potential for misuse</li>
                    <li>Interacts with some medications</li>
                    <li>May worsen respiratory depression with opioids</li>
                </ul>

                <h2>Tips for Use</h2>
                <ul>
                    <li>Take at consistent times</li>
                    <li>Start at bedtime (helps with drowsiness)</li>
                    <li>Be patient with titration</li>
                    <li>Report significant side effects</li>
                </ul>

                <h2>References</h2>
                <ol>
                    <li>Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. <em>Cochrane Database Syst Rev</em>. 2017;6(6):CD007938.</li>
                    <li>Goodman CW, Brett AS. Gabapentin and pregabalin for pain - is increased prescribing a cause for concern? <em>N Engl J Med</em>. 2017;377(5):411-414.</li>
                    <li>Calandre EP, Rico-Villademoros F, Slim M. An update on pharmacotherapy for the treatment of fibromyalgia. <em>Expert Opin Pharmacother</em>. 2015;16(9):1347-1368.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
